Treatment of Nrf2 activator DMF (HG/DMF) partly restored hyperglycemia-induced expression of IL1β and IL6, while it completely restored MCP1 expression compared to the HG/VEH group. The gene discussed is CCL2; the disease is Hyperglycemia.